Gender differences regarding interest in opioid agonist treatment with hydromorphone: a cross-sectional study of syringe service program participants
Abstract Background In the United States, only 15–20% of people with opioid use disorder (OUD) receive medications for OUD annually. Injectable opioid agonist treatment with hydromorphone (iOAT-H) is a novel approach that reduces non-prescribed opioid use. However, interest in iOAT-H among women, wh...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-08-01
|
| Seri Bilgileri: | Harm Reduction Journal |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12954-025-01300-1 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|